Moleculin Biotech (MBRX) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts MBRX Hot Sheet
Join SI Premium – FREE
Moleculin Biotech (NASDAQ: MBRX) reported Q2 EPS of ($0.20), $0.07 better than the analyst estimate of ($0.27).
For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Orosur Mining launches private placement targeting C$14M
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
